Rheumatic fever

Lancet

Volumn 349, Issue 9056, 1997, Pages 935-942

  Stollerman, Gene H ^a  

^a 21 The Courtyard ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT;

COMMUNITY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; HEART MUSCLE BIOPSY; HUMAN; PATHOGENESIS; POLYARTHRITIS; POPULATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; STREPTOCOCCUS INFECTION; VACCINE PRODUCTION;

EID: 0030894386     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)06364-7     Document Type: Review

References (35)

1. McLaren MJ, Markowitz MM. Rheumatic heart disease in developing countries: the consequence of inadequate prevention. Ann Intern Med 1994; 120: 243-45.
2. Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's northern territory. Med J Aust 1996; 164: 146-64.
3. Picherero ME. Cephalosporins are superior to penicillin for the treatment of tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J 1993; 123:268-74.
4. Little PS, Williamson I. Are antiobiotics appropriate for sore throats? BMJ 1994; 309: 1010-11.
5. Stollerman GH. The nature of rheumatogenic streptococci. Mt Sinai J Med 1996; 653: 144-57.
6. Centers for Disease Control: acute rheumatic fever - Utah. MMWR 1987; 36: 108.
7. Djani AS, Ayoub E, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones Criteria, updated 1993. Circulation 1993; 87: 302-07.
8. Vasan RS, Shrivastava S, Vijayakumar MD, et al. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation 1996; 94: 73-82.
9. Wilson NJ, Neutze JM. Editorial: echocardiographic diagnosis of subclinical carditis in acute rheumatic fever. Int J Cardiol 1995; 50: 1-6.
10. Narula J, Chopra P, Talwar KK, et al. Does endomyocardial biopsy aid in the diagnosis of active myocarditis? Circulation 1996; 88: 2198-205.
11. Maxted WR, Valkenburg HA. Variation in the M-antigen of group A streptococci. J Med Microbiol 1969; 2: 199-210.
12. Rothbard S, Watson RF. Variation occuring in group A streptococci during human infection: progressive loss of M substance correlated with increasing susceptibility to bacteriostasis. J Exp Med 1948; 87: 521-33.
13. Bisno AL, Pearce IA, Stollerman GH. Streptoccocal infections that fail to cause recurrences of rheumatic fever. J Infect Dis 1977; 136: 78-85.
14. Berrios X, delCampo E, Guzman B, Bisno AL. Discontinuing rheumatic fever prophylaxis in selected adolescents and young adults: a prospective study. Ann Intern Med 1993; 118: 401-06.
15. Wannamaker LW. Medical progress: differences between streptococcal infections of the throat and of the skin. N Engl J Med 1970; 282; 23, 78.
16. Potter EV, Svartman M, Mohammed I, et al. Tropical acute rheumatic fever and associated streptococcal infections compared with concurrent acute glomeruloephritis. J Pediatr 1978; 92: 325-33.
17. Bisno AL, Pearce IA, Wall HP, et al. Contrasting epidemiology of acute glomerulonephritis: nature of the antecedent streptoccocal infection. N Engl J Med 1970; 283: 561-65.
18. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336: 1167-71.
19. Kaplan EL. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. Circulation 1993; 88: 1964-72.
20. Bessen DE, Jones KF, Fischetti VA. Evidence for two distinct classes of streptococcal M-protein and their relationship to rheumatic fever. J Exp Med 1989; 169: 269-83.
21. Bessen DE, Veasy LG, Hill HR, Augustine NH, Fischetti VA. Serologic evidence for a class I group A streptococcal infection among rheumatic fever patients. J Infect Dis 1995; 172: 1608-11.
22. Bessen DE, Sotir CM, Readdy TL, Hollingshead SK. Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis 1996; 173: 896-900.
23. Dale JB, Chiang EC. Intranasal immunization with recombinant group A streptococcal M fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections. J Infect Dis 1995; 171: 1038-41.
24. Watanabe-Ohnishi R, Aelion J, LeGros L, et al. Characterization of unique human TCR V-beta specificities for a family if streptococcal superantigens represented by rheumatogenic serotypes of M protein. J Immunol 1994; 152: 2066-73.
25. Albert DA, Harel L, Karrison T. The treatment of rheumatic carditis: a review and metaanalysis. Medicine 1995; 74: 1-12.
26. Stollerman GH. Rheumatic carditis. Lancet 1995; 346: 390-91.
27. Marcus RH, Sareli P, Pocock WA, et al. The spectrum of severe rheumatic mitral disease in a developing country. Ann Intern Med 1994; 120: 177-83.
28. Djani A and the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the American Heart Association. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever. Pediatrics 1995; 96: 758-64.
29. Centers for Disease Control. Acute rheumatic fever among army trainees Fort Leonard Wood, Missouri, 1987-1988. MMWR 1988; 37: 519-22.
30. Veasy LG, Wiedmeier SE, Garth SO, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316: 421-27.
31. Beachey EH, Stollerman GH, Johnson RH, Ofek I, Bisno AL. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M Protein. J Exper Med. 1979; 150: 862-77.
32. Fischetti VA. Protection against group A streptococcal infection. In: Stevens DL, Kaplan EL, eds. Streptococcal infections. London: Oxford University Press (in press).
33. Dale JB. Type-specific multivalent group A streptococcal M protein vaccines. In: Stevens DL, Kaplan EL, eds. Streptococcal infections. London: Oxford University press (in press).
34. Hartas J, Goodfellow AM, Currie BS, Sriprakash KS. Characterization of group A streptococcal isolates from tropical Australia with high prevalence of rheumatic fever: probing for signature sequences to identify members of the family of serotype 5. Microb Pathog 1995; 18: 345-54.
35. Dale JB, Simmons M, Chiang EC, Chiang EY. Recombinant octavalent group A streptococcal vaccine. Vaccine 1996; 14: 944-48.